Who Should Not Take TRT? 20 Red Flags, Sorted by What to Do Next
By TRT Provider Guide Editorial Team · Last verified October 2026 · Editorial research, not clinically reviewed
Disclosure: TRT Provider Guide may earn compensation through certain provider links. Commercial relationships do not change our editorial conclusions. Read our affiliate disclosure.
Who should not take TRT? Men actively trying to conceive and men with active breast cancer or unresolved prostate cancer should not start routine testosterone therapy. Other problems — including high hematocrit, untreated severe sleep apnea, recent heart attack or stroke, uncontrolled heart failure, or an unchecked prostate concern — may mean wait, treat the problem first, or get specialist input.
That's the short answer. Here's the part most lists leave out: those are not all the same kind of "no."
Some are a hard stop. Some mean "fix this first, then ask again." Some need a specialist to make the call. And the most common one isn't a health problem at all — it's that the diagnosis was never finished. We sorted all 20 red flags into those four buckets, checked each one against the current FDA labels, the June 2026 FDA label request, the American Urological Association (AUA) and the Endocrine Society, and noted which test reveals each one and who to see.
This page is for you if: you're an adult man thinking about TRT and you want to know whether something in your health history changes the answer.
A checklist can't decide this alone: no quiz, symptom list, single lab result, or online form can clear you for testosterone. It can only tell you which questions still need an answer.
Educational information, not medical advice. Don't start, stop, or change testosterone because of this page. Chest pain, sudden shortness of breath, one swollen and painful leg, or signs of a stroke (face drooping, arm weakness, slurred speech) need emergency care now — call 911.
TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.
Who should not take TRT? The full list of 20 red flags
Twenty health situations change whether an adult man should start testosterone replacement therapy (TRT). Three are firm stops, seven mean "fix this first," six need a specialist's judgment, and four mean low testosterone hasn't been properly diagnosed yet. The table shows what U.S. rulebooks say about each one, which test reveals it, and who to see.
A quick key to the sources in the table:
- FDA label = the FDA-approved AndroGel 1.62% prescribing information we checked (revised July 2025). Product-specific labels differ, so the exact product label still matters.
- FDA 2026 request = label changes FDA asked manufacturers to make on June 18, 2026. Requested, not yet on every label.
- ES = Endocrine Society clinical practice guideline (2018) and its July 16, 2026 statement.
- AUA = American Urological Association testosterone deficiency guideline (2018, validity confirmed 2024).
The TRT Red-Flag Ledger (October 2026)
Sources for every row are listed at the bottom of this page. The four buckets are our editorial framework, built from the rules above.
A few terms, in plain English:
- Hematocrit is the percentage of your blood made of red blood cells. Testosterone can push it up.
- PSA (prostate-specific antigen) is a blood test used to screen for prostate problems, including cancer. A high PSA is a signal to look closer, not a diagnosis.
- LH (luteinizing hormone) is the signal your brain sends to your testes to make testosterone. It helps show whether the problem starts in the testes or the brain.
- Hypogonadism is the medical name for a body that doesn't make enough testosterone because of a problem in the testes, pituitary, or hypothalamus.
The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.
Who should not start TRT now?
Men with active breast cancer, men with known or suspected prostate cancer who have not been appropriately evaluated, and men actively trying to conceive should not start routine testosterone therapy. Current FDA labels and major guidelines do not treat all prostate-cancer situations the same way, so past treated disease belongs in a specialist decision rather than a blanket lifetime ban.
Breast cancer in men
Testosterone is on the "do not use" list for male breast cancer on every FDA label we checked, and the Endocrine Society recommends against starting it. That one isn't up for debate.
Known or suspected prostate cancer
Current FDA labels we checked still list known or suspected prostate cancer as a contraindication. In June 2026, FDA asked manufacturers to narrow that contraindication to metastatic prostate cancer, but requested changes do not appear on every product label at the same time.
The gray zone is men with localized cancer, treated cancer, or no current evidence of disease. The AUA says the evidence is not strong enough to quantify the risk-benefit ratio in men with a prostate-cancer history, so we cover that group in the specialist section below.
Trying to have a baby now
This is the stop that surprises people most. Testosterone from outside your body tells your brain to stop sending the signals your testes need to make sperm. The AUA says plainly that exogenous testosterone should not be prescribed to men currently trying to conceive. The next section explains why, and what to do instead.
Can you take TRT if you want kids?
If you're trying for a baby now, standard testosterone therapy isn't the right treatment — it can lower or stop sperm production. If you might want kids later, get a fertility check and talk about the long-term effect on sperm before your first dose, not after.
Here's how it works. Your brain sends two hormones, LH and FSH, to your testes. LH says "make testosterone." FSH helps say "make sperm." When testosterone comes from a shot, gel, or cream, your brain sees plenty of it and turns those signals down. The testosterone in your blood goes up. The testosterone inside the testes — the kind sperm production depends on — goes down.
What the evidence says about getting sperm back after stopping:
Nobody can promise you'll become infertile on TRT. Nobody can promise you'll recover either. That uncertainty is exactly why the order matters: fertility question first, prescription second.
What about clomiphene, enclomiphene, or hCG?
These are not TRT. They work by nudging your own body to make more testosterone instead of replacing it. The AUA says clinicians may use them in men with low testosterone who want to keep their fertility. It also notes that among these drugs, only hCG is FDA-approved for use in men. Enclomiphene is not FDA-approved. None of them comes with a fertility guarantee, whatever a sales page says.
If having a child is part of your plan, a reproductive urologist is the right first stop — not a general online TRT program, including the ones we work with.
Is a baby part of your plan? Find a urologist near you through the Urology Care Foundation → Not sure fertility applies to you? Find My TRT Path has a fertility-first route.
What should you fix before starting TRT?
Seven problems mean "not yet" rather than "never": a high hematocrit, untreated severe sleep apnea, a recent heart attack or stroke, uncontrolled heart failure, an unchecked high PSA or prostate lump, severe urinary symptoms, and uncontrolled blood pressure. Each one has a clear check, and once it's handled, many men can be reconsidered.
Is my hematocrit too high for TRT?
The AUA says that if your hematocrit is above 50% before treatment, your clinician should consider holding off until the cause is found. Once you're on testosterone, 54% or higher calls for intervention; the exact response depends on the testosterone level and the cause.
Here's why you may hear different numbers from different doctors. They're reading different rulebooks:
The last row comes from TRT Provider Guide's TRT Guidelines Data audit of eight current clinical guidelines, verified September 2, 2026.
If your number is already high, expect a slower, more careful start — not a door slammed shut. The AUA lists causes of secondary erythrocytosis such as tobacco use, obstructive sleep apnea, chronic lung disease, and high altitude, and notes that injectable testosterone tends to produce the greatest increases in hemoglobin and hematocrit among common treatment formats.
One thing not to do: don't donate blood just to get a number under a clinic's line. A high hematocrit is a signal to find the cause, not a hurdle to clear.
Can you take TRT with sleep apnea?
Untreated severe obstructive sleep apnea is the blocker — the Endocrine Society recommends against starting testosterone with it. Treated sleep apnea is a different situation, and the European Association of Urology's 2026 guideline found no evidence linking testosterone to mild, moderate, or CPAP-treated severe sleep apnea.
If you snore loudly, stop breathing at night, or wake up tired no matter how long you sleep, ask for a sleep study first. Untreated sleep apnea can drain energy on its own, and it can also push hematocrit up. Treating it might fix more than you expect.
How long after a heart attack or stroke can you start TRT?
The Endocrine Society says not within six months of a heart attack or stroke. The AUA says to wait three to six months after a cardiovascular event and then consider testosterone only with close monitoring.
Your cardiologist should be part of that decision. Bring them the TRAVERSE numbers below.
Can you take TRT with heart failure?
Uncontrolled heart failure is a reason not to start, per the Endocrine Society. Testosterone can make the body hold salt and water, and the FDA label warns that this swelling can be serious in people with heart disease. The key word is uncontrolled. Stable, well-managed heart failure is a cardiology conversation, not an automatic no.
What PSA level stops TRT?
The Endocrine Society says a urologist should check things first if your PSA is over 4 ng/mL, over 3 ng/mL if you're at higher risk, or if a prostate lump is found. The AUA says to measure PSA before starting in men over 40 and to get a formal workup if two results look suspicious.
"Higher risk" here means Black men and men whose father or brother had prostate cancer. A high PSA is not a cancer diagnosis. It's a reason to look closer before adding testosterone. TRT can raise PSA a little, so a clean baseline matters. See what blood tests are used before TRT for the full starting panel.
Can you take TRT with an enlarged prostate?
Severe urinary symptoms from an enlarged prostate (BPH) are a reason to see urology first. In June 2026, FDA said trials did not show worsening in men with mild-to-moderate BPH, so it asked for the warning to be relaxed, with continued monitoring for severe cases.
Common lower-urinary-tract symptoms include getting up many times a night, a weak stream, urgency, or trouble starting to urinate. Severe symptoms need evaluation before a routine TRT start.
Can you take TRT with high blood pressure?
High blood pressure isn't an automatic no, but uncontrolled high blood pressure is a reason to wait. Since 2025, every testosterone product carries a blood-pressure warning, and the AndroGel 1.62% label says it is not recommended for men with uncontrolled hypertension.
The size of the bump, from the AndroGel label's 24-hour monitoring study:
The average change was small in that study, but the label warns that blood-pressure increases can raise cardiovascular risk over time. If treatment is started, blood pressure should be monitored as the prescriber recommends.
Which health conditions need a specialist's call before TRT?
Six situations aren't automatic no's but need a specific risk talk with the right specialist: past blood clots or a clotting disorder, atrial fibrillation, prostate cancer treated in the past, heart, kidney, or liver disease with swelling, certain medicines, and wanting children someday.
Blood clots or a clotting disorder
The Endocrine Society recommends against starting testosterone in men with thrombophilia, a condition that makes blood clot too easily. In the TRAVERSE trial, blood clots in the lungs (pulmonary embolism) happened in 0.9% of men on testosterone vs. 0.5% on placebo. The Endocrine Society's July 2026 statement called that roughly a 50% relative increase. If you have thrombophilia or a prior clot history, that history needs to be part of the treatment decision; thrombophilia is specifically on the Endocrine Society's no-start list.
Atrial fibrillation
AFib was more common on testosterone in TRAVERSE: 3.5% vs. 2.4%. No guideline we checked bans testosterone for men with AFib. But if you already have it, your cardiologist should know before you start.
Prostate cancer treated in the past
This is where the rules are moving fastest.
- The FDA labels we checked still list known or suspected prostate cancer as a contraindication.
- FDA's June 2026 request would limit the contraindication to metastatic cancer.
- The AUA says patients with a prostate cancer history should be told there isn't enough evidence to measure the risk-benefit ratio. It calls the decision a negotiated one, and says testosterone can be considered after surgery with favorable results and an undetectable PSA.
Translation: no website should give you a blanket yes or no here. This belongs with a urologic oncologist who knows your cancer.
Heart, kidney, or liver disease with swelling
Testosterone can cause the body to hold onto salt and water. The FDA label warns this swelling, with or without heart failure, can be a serious problem in people with existing heart, kidney, or liver disease. TRAVERSE also found more acute kidney injury on testosterone (2.3% vs. 1.5%).
Blood thinners, insulin, or corticosteroids
The FDA label flags all three:
- Blood thinners (like warfarin): testosterone can change how well they work, so clotting tests may need checking more often.
- Insulin: testosterone may lower blood sugar, so insulin needs could drop.
- Corticosteroids (like prednisone): used together, they can add to fluid retention.
None of these is an automatic stop. All of them need your prescriber and pharmacist in the loop.
What did the big 2023 heart trial show?
TRAVERSE is the study behind the 2025 and 2026 label changes. It followed about 5,200 men aged 45 to 80 who had low testosterone and either heart disease or high heart risk. Average follow-up was 33 months.
Source: TRAVERSE results as printed in the FDA-approved AndroGel 1.62% label, July 2025.
What it showed: in that study population, testosterone was noninferior to placebo for the combined cardiovascular outcome of cardiovascular death, nonfatal heart attack, or nonfatal stroke. What it did not settle: safety in men without appropriately diagnosed hypogonadism or long-term prostate-cancer risk. The Endocrine Society's July 2026 statement says important long-term safety questions remain.
Who isn't ready for TRT because low testosterone isn't proven yet?
You're not ready for TRT if you only have symptoms, only one test, or a test that wasn't done in the early morning. Guidelines require symptoms or signs plus at least two early-morning tests showing consistently low testosterone, and a search for the cause.
This is the biggest bucket by far. And it's the easiest one to fix.
Symptoms alone aren't a diagnosis
Low energy, low sex drive, poor sleep, low mood, weaker workouts — those are real. They also have dozens of causes. The Endocrine Society's July 2026 statement says it directly: symptoms alone are not diagnostic. A good clinician rules out the common culprits first: poor sleep, depression, thyroid problems, alcohol, medicines, and weight.
One low test isn't a diagnosis
Testosterone swings during the day and from day to day. It's highest in the morning and can drop after a bad night, a big meal, or an illness. The AUA requires two early-morning tests on separate days. The Endocrine Society's 2026 statement says at least two early-morning fasting tests, ideally using a lab method certified by the CDC's hormone standardization program. See do you need two low testosterone tests for TRT and what testosterone level qualifies for TRT.
Very low testosterone can point to the brain, not the testes
If your testosterone is low and your LH is low or "normal," the problem may start in the pituitary gland. The AUA says to check prolactin in that case and to get a pituitary MRI if testosterone is under 150 ng/dL with low or low-normal LH. A pituitary tumor needs an endocrinologist — testosterone alone would cover it up, not fix it.
Some low testosterone has a fixable cause
The Endocrine Society says to rule out reversible contributors first, including obesity and medicines such as corticosteroids or opioids. Its July 2026 statement says weight loss is typically first-line when appropriately diagnosed hypogonadism is linked to overweight or obesity and no other cause is found. The AUA also recommends lifestyle counseling for men with testosterone deficiency. That doesn't mean "go to the gym and you'll be fine." It means the cause matters to the treatment decision.
Not sure which bucket you're in? That's normal — most people land in more than one. Use Find My TRT Path to build your next-step plan before you pay anyone →
What changed in 2025 and 2026? Is TRT safer now?
In February 2025, FDA removed the heart-attack-and-stroke language from testosterone's boxed warning and added a blood-pressure warning to every product. In June 2026, FDA asked manufacturers to narrow the prostate cancer contraindication to metastatic cancer, relax the enlarged-prostate warning, and drop the "age-related low T" limitation. Screening and monitoring still apply.
FDA's June 2026 action was a request to manufacturers. Check the current label on the exact product you're prescribed, because labels update on their own timelines.
So, is TRT "safe now"? The label changed because the evidence changed, but that does not make TRT risk-free. HHS said prostate cancer can take years to develop and existing studies may not have followed men long enough to settle long-term risk. Screening and monitoring still matter.
Our take: looser label, same homework. The Endocrine Society's 2018 clinical guideline remains its published guideline in 2026, while the Society's July 2026 statement also recognizes the newer TRAVERSE evidence and the questions that remain.
Is a "contraindication" the same as a warning?
No. A contraindication on an FDA label means the drug should not be used. A warning means a risk to watch and manage. A guideline's "recommend against starting" is expert advice that can cover more situations than the label does. Online lists often mix all three together.
That's why one site says sleep apnea "rules you out" and another says it doesn't. Here's how to tell them apart:
Most of the 20 red flags on this page come from the third row. They're strong advice, not legal bans. A specialist can weigh them for your case. A one-page online intake usually can't.
What if a doctor says no — or an online clinic says yes?
If a doctor says no, ask which reason they're using: a stop, a fix-first issue, or a judgment call. A hard-stop or specialist issue does not disappear because a different clinic is willing to prescribe. Fix-first issues may change after the underlying problem is addressed. Judgment calls are where a second opinion from the appropriate specialist can make sense. And an online "yes" should never override an unresolved red flag on this list.
Getting told no when you feel lousy is frustrating. It doesn't always mean never. Bring these three questions to the follow-up:
- "Which specific issue stopped this?"
- "Is it permanent, or can it change?"
- "What would need to happen before you'd reconsider?"
If the answer is a fix-first item, you now have a plan. If it's a judgment call — a borderline lab, an older guideline, a gray-zone condition — a second opinion from endocrinology or urology is reasonable.
What isn't reasonable: shopping for a clinic that won't ask about the reason. Testosterone is a Schedule III controlled substance under federal law and requires a valid prescription. A program that skips the reason your doctor gave isn't a second opinion. It's a workaround.
The flip side matters too. Eligible for a consultation is not the same as cleared for treatment. If an online program says "you qualify" and you know something in the Stop, Fix First, or Specialist buckets applies to you, tell them — and see the right specialist first.
Who is a reasonable candidate to talk about TRT?
TRT is reasonable to discuss when an adult man has symptoms or signs of low testosterone, at least two early-morning tests showing consistently low levels, a known or investigated cause, his fertility plans settled, and none of the Stop or Fix First red flags. Even then, it's a decision to make with a clinician, not a guarantee.
If that sounds like you, here's what a properly run start looks like. Use it to judge any doctor or program:
Questions to bring to your appointment
Copy these, or print this section:
- Have my results actually confirmed low testosterone, or should I repeat the test?
- What do you think is causing it? Could a medicine, my weight, or my sleep be part of it?
- Is my hematocrit safe to start? Is my PSA?
- Do I need a sleep study first?
- Does my heart history or blood-clot history change your recommendation?
- I may want kids — should I see a reproductive urologist first?
- Which exact product would I get? Is it FDA-approved or compounded?
- What will you monitor, how often, and what would make us stop?
Have these answers already, or want help sorting them? Use Find My TRT Path to build your next-step plan →
For the follow-up schedule after you start, see how often you should get bloodwork on TRT.
What should an online TRT program check before prescribing?
Online care does not change the medical standard. Before prescribing testosterone, a clinician still needs enough history, examination or other evaluation when indicated, and laboratory evidence to confirm the diagnosis and identify safety issues that could make treatment inappropriate or premature. An intake form or marketing eligibility screen is not the same as medical clearance.
At minimum, the published medical guidance on this page supports checking the diagnosis, fertility plans, hemoglobin and hematocrit, prostate risk when indicated, cardiovascular history, sleep-apnea history, current medicines, and the likely cause of low testosterone. The exact workup can be broader depending on the person.
If a telehealth program says you are "eligible for a consultation," read that literally. A consultation is a chance for a licensed clinician to evaluate you; it is not a promise that testosterone will be prescribed.
Not sure whether online TRT, primary care, urology, endocrinology, or reproductive urology fits your situation? Use Find My TRT Path to map the right care route and the questions to ask before you pay →
What we actually verified
Last verified: October 4, 2026
Primary and official sources checked:
- FDA-approved AndroGel labeling, including the July 2025 cardiovascular and blood-pressure revisions
- FDA's February 28, 2025 class-wide testosterone labeling action
- HHS/FDA's June 18, 2026 requested testosterone-label updates
- Endocrine Society 2018 clinical practice guideline and July 16, 2026 statement
- AUA Testosterone Deficiency Guideline (2018; validity confirmed 2024)
- VA Testosterone Replacement Therapy in Males Criteria for Use (March 2025)
- European Association of Urology 2026 Male Hypogonadism guideline
- DEA's fourth temporary telemedicine extension through December 31, 2026
Verified directly:
- the Endocrine Society's no-start conditions
- the AUA baseline hematocrit threshold above 50% and on-treatment intervention threshold of 54%
- the AUA recommendation not to prescribe exogenous testosterone to men currently trying to conceive
- the current FDA-label distinction between formal contraindications and warnings/precautions
- TRAVERSE event rates printed in current AndroGel labeling
- the 2025 class-wide blood-pressure labeling change
- the June 2026 requested prostate, BPH, and age-related-hypogonadism labeling revisions
- testosterone's Schedule III status and the federal telemedicine extension through December 31, 2026
What this verification does not establish: It does not tell any individual reader that TRT is safe, unsafe, indicated, or contraindicated for them. Product labels also differ, so the prescriber should check the current labeling for the exact testosterone product being considered.
Who should avoid testosterone gel or cream specifically?
Men who may have skin-to-skin contact with children or a pregnant partner need a strict transfer-prevention plan if an FDA-approved testosterone gel is prescribed. Testosterone gel can transfer from an application site to another person, and FDA-approved gel labels carry a boxed warning about secondary exposure.
FDA labeling reports virilization in children after secondary exposure to testosterone gel and tells children and women to avoid contact with unwashed or unclothed application sites. Pregnant women should avoid exposure because testosterone can cause fetal harm. The AUA says clinicians should discuss transfer risk with patients using topical testosterone.
If you cannot reliably follow the transfer-prevention steps for the exact topical product prescribed, ask your prescriber whether a different treatment format would be safer for your household.
Who is this page not for?
This page covers adult men evaluating testosterone for low testosterone. It is not the right guide for women, anyone under 18, gender-affirming hormone care, or using testosterone to build muscle or improve performance.
- Women: Testosterone products for men are not indicated for women, and they are contraindicated in pregnancy. Talk to a menopause-trained clinician or OB-GYN.
- Under 18: Safety and effectiveness haven't been established. Improper use can affect bone growth. See a pediatric endocrinologist.
- Gender-affirming care: This follows separate clinical standards. See a gender-affirming care specialist.
- Bodybuilding or performance: This isn't medical TRT. The FDA label warns that testosterone misuse can cause serious heart and psychiatric harm, and men with normal levels gain no approved medical benefit. We don't give dosing, sourcing, or cycling information.
Frequently asked questions
What disqualifies you from TRT?
The clearest no-start situations include active breast cancer, known or suspected prostate cancer that has not been appropriately evaluated, and actively trying to conceive. Many other issues — a high hematocrit, untreated severe sleep apnea, a recent heart attack or stroke, uncontrolled heart failure, or an unchecked high PSA — may mean "not yet" or "specialist first" rather than "never." Not having a confirmed diagnosis also means you're not ready yet.
Is there an age limit for TRT?
No age cutoff decides it. The Endocrine Society's 2026 statement says the diagnosis works the same way at any age. Its 2018 guideline advises against routinely prescribing testosterone to every man 65 or older with low levels. In June 2026, FDA asked labels to drop the line saying safety in "age-related" low testosterone hadn't been established.
Can you take TRT with high blood pressure?
Controlled blood pressure isn't an automatic no. But all testosterone products now carry a blood-pressure warning, and the AndroGel 1.62% label says it isn't recommended for uncontrolled hypertension. Get it under control first, then plan regular home checks.
Can you take TRT if your hematocrit is high?
The AUA says that if your hematocrit is above 50% before starting, your clinician should consider holding off until the cause is found. That's usually a pause, not a permanent ban. Common causes to rule out include smoking, sleep apnea, lung disease, and high altitude.
Can you take TRT with sleep apnea?
Untreated severe obstructive sleep apnea is a reason not to start, per the Endocrine Society. Treated sleep apnea is different. If you're on CPAP and it's working, it's a conversation with your clinician, not an automatic no.
Can you take TRT after a heart attack?
The Endocrine Society says not within six months of a heart attack or stroke. The AUA says wait three to six months, then consider testosterone only with close monitoring. Your cardiologist should be involved.
Can you take TRT if you've had a blood clot?
It needs a specialist's input. The Endocrine Society recommends against starting with a clotting disorder, and the TRAVERSE trial found more lung clots on testosterone (0.9% vs. 0.5%).
Can you take TRT after prostate cancer?
It depends on the cancer. Metastatic prostate cancer is a firm no. For prostate cancer treated in the past, the AUA says there isn't enough evidence to measure the risk vs. benefit, and FDA's 2026 request would loosen the label for non-metastatic cases. This decision belongs with a urologic oncologist.
Can you take TRT if you want kids later, not now?
Possibly, but talk about it first. The AUA says the long-term effect on sperm should be discussed before treatment and recommends a reproductive health evaluation. Recovery after stopping varies. Some men take a year or longer, and recovery is not guaranteed.
Can you take TRT if you have diabetes?
Diabetes alone doesn't rule you out. But the Endocrine Society recommends against using testosterone as a way to improve blood sugar control. If you take insulin, testosterone may lower your blood sugar, so your doctor may need to adjust your dose.
Can you take TRT if your testosterone is "low-normal"?
Usually not without more workup. Diagnosis needs symptoms plus consistently low results on proper morning tests, and the cutoffs differ between guidelines. A borderline number may need free testosterone and SHBG (the protein that binds testosterone) to interpret. See what testosterone level qualifies for TRT.
Why do some doctors refuse to prescribe testosterone?
Usually because the diagnosis is not confirmed, a red flag on this list applies, or the clinician believes the risks outweigh the likely benefits in that person. Ask which reason applies. That tells you whether the next step is more testing, treating another problem, a specialist opinion, or a different path.
Can an online clinic prescribe testosterone without an in-person visit in 2026?
Under the federal temporary extension in effect through December 31, 2026, DEA-registered practitioners may prescribe Schedule II–V controlled medications through qualifying telemedicine encounters without a prior in-person medical evaluation when all federal and state requirements are met. Testosterone is Schedule III. State law and individual programs can still require an in-person exam, so re-check the rule after December 31, 2026.
Is TRT safe now that FDA changed the label?
The 2025 cardiovascular-label change and the June 2026 requested prostate/BPH revisions reflect newer evidence, including TRAVERSE. FDA still requires class-wide blood-pressure warnings, and HHS says long-term prostate-cancer risk is not fully settled. The changes do not make TRT risk-free.
How we built this page
We read the issuing bodies' own documents — not summaries — and recorded what each one says about starting testosterone. Those documents are the FDA product labels, FDA's 2025 and 2026 actions, the AUA guideline, the Endocrine Society's 2018 guideline and 2026 statement, and the VA's criteria. We then sorted each condition into one of four buckets based on how strongly and consistently those sources speak. The buckets are our editorial framework. Where the sources disagree, we show the disagreement rather than picking one.
For the broader dataset behind several numbers here, including how eight current guidelines handle hematocrit, fertility, and testing, see our TRT Guidelines Data: 10 Guidance Sets Compared. Our provider-review standards are documented in How We Review TRT Providers; this page itself is a medical-information guide rather than a provider ranking.
This page is educational information, not medical advice, and it was not clinically reviewed. It can't tell you whether testosterone is right for you. A licensed clinician who knows your history and reviews proper testing should make that decision with you.
Sources
- U.S. Food and Drug Administration. AndroGel (testosterone gel) 1.62% prescribing information, revised July 2025.
- U.S. Food and Drug Administration. FDA issues class-wide labeling changes for testosterone products, February 28, 2025.
- U.S. Department of Health and Human Services. HHS Announces Requested Updates to Testosterone Therapy Product Labels, June 18, 2026.
- Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2018.
- Endocrine Society. Statement on Testosterone Replacement Therapy, July 16, 2026.
- Mulhall JP, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol, 2018; validity confirmed 2024.
- U.S. Department of Veterans Affairs. Testosterone Replacement Therapy in Males: Criteria for Use, March 2025.
- Lincoff AM, et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). N Engl J Med, 2023.
- European Association of Urology. Sexual and Reproductive Health Guideline, Male Hypogonadism chapter, 2026 edition.
- TRT Provider Guide. TRT Guidelines Data: 10 Current Guidance Sets Compared (2026), verified September 2, 2026.
- U.S. Drug Enforcement Administration. DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care, December 31, 2025.
- U.S. Drug Enforcement Administration. Drug Scheduling.
Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.